Prednisone Plus Chloroquine for the Treatment of Hyper-reactive Malarial Splenomegaly

NCT01785979 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Lack of funding

Conditions

Hyper-reactive Malarial Splenomegaly
Malaria
Anaemia

Interventions

DRUG: prednisone induction - chloroquine
DRUG: Chloroquine

Sponsor

Lihir Medical Centre